Apollomics, Inc.
Apollomics, Inc. (APLM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APLM · as of Jun 8, 2026
Key Statistics
Explore Apollomics, Inc. Data
aplm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
aplm competitorsAPLM
ADAP
ANL
ATHA
BLRX
GOVXStock Performance
Full HistoryAbout Apollomics, Inc.
Apollomics, Inc. a biotechnology company, engages in the discovery and development of oncology therapies to address unmet medical needs in California, Hangzhou, Shanghai, China, and Australia. It dev…
what is apollomics, inc. · aplm stock overview · apollomics, inc. company profile · who is apollomics, inc. ceo · aplm NASDAQ · apollomics, inc. headquarters · apollomics, inc. business segments
About Stock Overview & Key Data
Apollomics, Inc. (APLM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 26, 2021. As of the latest trading session, APLM stock price is $14.00, with a market capitalization of $15.4M. The stock has returned +110.53% over the past 12 months and -25.13% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Apollomics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Apollomics, Inc. reported revenue of $8.5M and net income of -$10.9M. For detailed data — including Apollomics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Apollomics, Inc. (APLM) stock price is $14.00. The stock is traded on NASDAQ under the ticker symbol APLM. The 52-week range is $3.66 – $42.12.